Quince Therapeutics Inc.
1.76
0.05 (2.92%)
At close: Jan 15, 2025, 3:59 PM
1.76
0.00%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -1.25 -0.41 -4.2 -10.55 -29.04 -56.81 -57.93
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 0.46 0.21 3.16 4.71 9.25 9.92 -34.95
P/FCF Ratio -2.12 -0.48 -5.94 -15.93 -32.05 -59.53 -71.57
P/OCF Ratio -2.14 -0.48 -5.96 -15.95 -32.11 -60.61 -72.13
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.16 0.00 0.01 0.00 n/a n/a -0.35
Quick Ratio 8.09 29.80 7.69 8.11 11.93 49.82 4.28
Current Ratio 8.09 30.55 7.85 8.11 11.93 49.82 4.28
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -91.58 n/a n/a n/a -12.66 -6.31
Return on Equity (ROE) -0.37 -0.51 -0.75 -0.45 -0.32 -0.17 0.60
Return on Assets (ROA) -0.19 -0.5 -0.67 -0.41 -0.3 -0.17 -1.59
Return on Capital (ROIC) -0.22 -0.52 -0.76 -0.46 -0.34 -0.17 -1.74
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a

Create Price Alert on QNCX

Your price alert will notify you when the stock price is above 1.76.

Add to Watchlist